Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)
29,950
-250 (-0.83%)
Last updated: Sep 19, 2025, 11:37 AM KST
Daihan Pharmaceutical Market Cap
Daihan Pharmaceutical has a market cap or net worth of 175.52 billion as of September 19, 2025. Its market cap has increased by 12.01% in one year.
Market Cap
175.52B
Enterprise Value
76.91B
Revenue
207.68B
Ranking
n/a
PE Ratio
5.60
Stock Price
29,950.00
Market Cap Chart
Since March 1, 2001, Daihan Pharmaceutical's market cap has increased from 22.26B to 175.52B, an increase of 688.49%. That is a compound annual growth rate of 8.77%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 19, 2025 | 175.52B | 13.93% |
Dec 30, 2024 | 154.06B | -5.59% |
Dec 28, 2023 | 163.17B | -11.13% |
Dec 29, 2022 | 183.60B | 6.62% |
Dec 30, 2021 | 172.20B | -12.90% |
Dec 30, 2020 | 197.70B | 4.11% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 525.28T |
SK hynix | 243.72T |
LG Energy Solution | 82.95T |
Samsung Biologics | 73.24T |
Hanwha Aerospace | 52.63T |
Hyundai Motor Company | 47.73T |
HD Hyundai Heavy Industries | 44.34T |
KB Financial Group | 42.75T |